Cargando…

Immunosuppression and Resultant Viral Persistence by Specific Viral Targeting of Dendritic Cells

Among cells of the immune system, CD11c(+) and DEC-205(+) splenic dendritic cells primarily express the cellular receptor (α-dystroglycan [α-DG]) for lymphocytic choriomeningitis virus (LCMV). By selection, strains and variants of LCMV that bind α-DG with high affinity are associated with virus repl...

Descripción completa

Detalles Bibliográficos
Autores principales: Sevilla, Noemí, Kunz, Stefan, Holz, Andreas, Lewicki, Hanna, Homann, Dirk, Yamada, Hiroki, Campbell, Kevin P., de la Torre, Juan C., Oldstone, Michael B.A.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2000
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193355/
https://www.ncbi.nlm.nih.gov/pubmed/11067874
_version_ 1782147451345436672
author Sevilla, Noemí
Kunz, Stefan
Holz, Andreas
Lewicki, Hanna
Homann, Dirk
Yamada, Hiroki
Campbell, Kevin P.
de la Torre, Juan C.
Oldstone, Michael B.A.
author_facet Sevilla, Noemí
Kunz, Stefan
Holz, Andreas
Lewicki, Hanna
Homann, Dirk
Yamada, Hiroki
Campbell, Kevin P.
de la Torre, Juan C.
Oldstone, Michael B.A.
author_sort Sevilla, Noemí
collection PubMed
description Among cells of the immune system, CD11c(+) and DEC-205(+) splenic dendritic cells primarily express the cellular receptor (α-dystroglycan [α-DG]) for lymphocytic choriomeningitis virus (LCMV). By selection, strains and variants of LCMV that bind α-DG with high affinity are associated with virus replication in the white pulp, show preferential replication in a majority of CD11c(+) and DEC-205(+) cells, cause immunosuppression, and establish a persistent infection. In contrast, viral strains and variants that bind with low affinity to α-DG are associated with viral replication in the red pulp, display minimal replication in CD11c(+) and DEC-205(+) cells, and generate a robust anti-LCMV cytotoxic T lymphocyte response that clears the virus infection. Differences in binding affinities can be mapped to a single amino acid change in the viral glycoprotein 1 ligand that binds to α-DG. These findings indicate that receptor–virus interaction on dendritic cells in vivo can be an essential step in the initiation of virus-induced immunosuppression and viral persistence.
format Text
id pubmed-2193355
institution National Center for Biotechnology Information
language English
publishDate 2000
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21933552008-04-16 Immunosuppression and Resultant Viral Persistence by Specific Viral Targeting of Dendritic Cells Sevilla, Noemí Kunz, Stefan Holz, Andreas Lewicki, Hanna Homann, Dirk Yamada, Hiroki Campbell, Kevin P. de la Torre, Juan C. Oldstone, Michael B.A. J Exp Med Original Article Among cells of the immune system, CD11c(+) and DEC-205(+) splenic dendritic cells primarily express the cellular receptor (α-dystroglycan [α-DG]) for lymphocytic choriomeningitis virus (LCMV). By selection, strains and variants of LCMV that bind α-DG with high affinity are associated with virus replication in the white pulp, show preferential replication in a majority of CD11c(+) and DEC-205(+) cells, cause immunosuppression, and establish a persistent infection. In contrast, viral strains and variants that bind with low affinity to α-DG are associated with viral replication in the red pulp, display minimal replication in CD11c(+) and DEC-205(+) cells, and generate a robust anti-LCMV cytotoxic T lymphocyte response that clears the virus infection. Differences in binding affinities can be mapped to a single amino acid change in the viral glycoprotein 1 ligand that binds to α-DG. These findings indicate that receptor–virus interaction on dendritic cells in vivo can be an essential step in the initiation of virus-induced immunosuppression and viral persistence. The Rockefeller University Press 2000-11-06 /pmc/articles/PMC2193355/ /pubmed/11067874 Text en © 2000 The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Original Article
Sevilla, Noemí
Kunz, Stefan
Holz, Andreas
Lewicki, Hanna
Homann, Dirk
Yamada, Hiroki
Campbell, Kevin P.
de la Torre, Juan C.
Oldstone, Michael B.A.
Immunosuppression and Resultant Viral Persistence by Specific Viral Targeting of Dendritic Cells
title Immunosuppression and Resultant Viral Persistence by Specific Viral Targeting of Dendritic Cells
title_full Immunosuppression and Resultant Viral Persistence by Specific Viral Targeting of Dendritic Cells
title_fullStr Immunosuppression and Resultant Viral Persistence by Specific Viral Targeting of Dendritic Cells
title_full_unstemmed Immunosuppression and Resultant Viral Persistence by Specific Viral Targeting of Dendritic Cells
title_short Immunosuppression and Resultant Viral Persistence by Specific Viral Targeting of Dendritic Cells
title_sort immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193355/
https://www.ncbi.nlm.nih.gov/pubmed/11067874
work_keys_str_mv AT sevillanoemi immunosuppressionandresultantviralpersistencebyspecificviraltargetingofdendriticcells
AT kunzstefan immunosuppressionandresultantviralpersistencebyspecificviraltargetingofdendriticcells
AT holzandreas immunosuppressionandresultantviralpersistencebyspecificviraltargetingofdendriticcells
AT lewickihanna immunosuppressionandresultantviralpersistencebyspecificviraltargetingofdendriticcells
AT homanndirk immunosuppressionandresultantviralpersistencebyspecificviraltargetingofdendriticcells
AT yamadahiroki immunosuppressionandresultantviralpersistencebyspecificviraltargetingofdendriticcells
AT campbellkevinp immunosuppressionandresultantviralpersistencebyspecificviraltargetingofdendriticcells
AT delatorrejuanc immunosuppressionandresultantviralpersistencebyspecificviraltargetingofdendriticcells
AT oldstonemichaelba immunosuppressionandresultantviralpersistencebyspecificviraltargetingofdendriticcells